AbCellera Biologics (ABCL) EPS (Basic) (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly EPS (Basic) came in at -$0.14 in Q1 2026, up 7.06% YoY from -$0.13 in Q1 2025, and down 375.61% on a QoQ basis from -$0.03 in Q4 2025.
AbCellera Biologics (ABCL) EPS (Basic) (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of EPS (Basic) data on file, last reported at -$0.14 in Q1 2026.
- Quarterly EPS (Basic) rose 7.06% year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.47 (up 15.77% YoY) and the FY2025 annual result came in at -$0.49, up 11.42% from the prior year.
- EPS (Basic) slipped to -$0.14 in Q1 2026, from -$0.03 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.59 in Q1 2022 to a low of -$0.19 in Q3 2025.
- A 5-year average of -$0.07 and a median of -$0.12 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 221.74% — and 2023, when it sank 343.36%.
- Tracing ABCL's EPS (Basic) over 5 years: stood at -$0.1 in 2022, then tumbled by 55.49% to -$0.16 in 2023, then climbed by 28.72% to -$0.12 in 2024, then soared by 74.24% to -$0.03 in 2025, then slumped by 375.61% to -$0.14 in 2026.
- The last three EPS (Basic) figures came in at -$0.14 (Q1 2026), -$0.03 (Q4 2025), and -$0.19 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.14 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | -0.08 |